Kiadis Pharma
04/06/2018
Kiadis Pharma sounds the gong in Amsterdam
Kiadis Pharma (ticker symbol: KDS), received this year’s tech 40 label from Euronext. Companies with the Tech 40 label are young technology companies listed on Euronext markets and operating in life sciences, eco-industries or TMT. An independent group of European experts selected the first 40 on the basis of their business, financial and stock market performance.
Kiadis Pharma is a clinical stage biopharmaceutical company focused on research, development and future commercialisation of cell-based immunotherapy products for the treatment of blood cancers and inherited blood disorders.
For more information: www.kiadis.com